This startup develops a disposable glucose monitoring device that uses advanced biosensing and machine learning to provide continuous, real-time physiological data. Their product aims to make glucose monitoring more accessible and affordable for patients.
Funding
Funding not disclosed
Founders
Product
Problem
Over 90% of individuals with type 2 diabetes do not utilize continuous glucose monitoring (CGM) systems despite the demonstrated clinical benefits, primarily due to limited access and high costs associated with existing solutions. Traditional CGMs can be invasive, requiring needles for insertion, and may not be affordable for many patients.
Solution
One Health Biosensing offers a next-generation intradermal continuous glucose monitoring (CGM) device designed to be affordable and accessible. The system utilizes a micro-needle sensing platform that eliminates the need for needles, providing a pain-free experience. The device incorporates a reusable battery pod and a daily disposable sensor to minimize costs. AI-enabled precision guidance informs action and improves health outcomes, even on non-CGM days. The system is engineered to provide a customizable CGM experience, meeting diverse lifestyle, health needs, and budgetary requirements.
Target Audience
The primary target audience includes individuals with type 2 diabetes who are not currently using CGM systems due to cost or invasiveness, as well as those recently diagnosed or seeking better glycemic control.
Features
- Intradermal sensor technology that does not require needles
- Reusable battery pod and disposable sensor design to minimize costs
- AI-enabled precision guidance for improved health outcomes
- Customizable CGM experience with flexible wear options
- Real-time, continuous glucose monitoring
- Durable applicator, battery, and transmitter designed for reusability to minimize single-use plastic and reduce medical waste